ENDONOVO THERAPEUTICS, INC. (ENDV) › Cash & EquivalentsENDONOVO THERAPEUTICS, INC. (ENDV) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $49.2K2010: $34.8K2011: $9.4K2012: $8002013: $3.3K2014: $9882015: $41.5K2016: $55.5K2017: $90.2K2018: $379.2K2019: $18.9K2020: $13.4K2021: $85.9K$85.9K2009Cash & Equivalents (USD)2021Fiscal YearCash & EquivalentsChange YoY2021$85.9K+540.4%2020$13.4K-29.0%2019$18.9K-95.0%2018$379.2K+320.5%2017$90.2K+62.4%2016$55.5K+33.9%2015$41.5K+4097.7%2014$988-69.6%2013$3.3K+306.9%2012$800-91.5%2011$9.4K-72.8%2010$34.8K-29.4%2009$49.2K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share